Hemant Surgical Industries Board of Directors

Get the latest insights into the leadership at Hemant Surgical Industries. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Mr. Hanskumar Shah Chairman & Managing Director
Mr. Kaushik Hanskumar Shah WholeTime Director & CFO
Mr. Hemant Praful Shah Whole Time Director
Mrs. Nehal Babu Karelia Non Executive Director
Mr. Ketan Chandrakat Dave Independent Director
Mrs. Kshama Dharnidharka Independent Director

Hemant Surgical Industries Share price

HSIL

301.05

3.35 (-1.10%)
Last updated on 15 Oct, 2025 | 15:28 IST
BUYSELL
Today's High

308.00

Today's Low

301.05

52 Week Low

88.15

52 Week High

367.10

The current prices are delayed, login to your account for live prices

Hemant Surgical Industries FAQs

The board at Hemant Surgical Industries consists of experienced professionals, including Mr. Hanskumar Shah , Mr. Kaushik Hanskumar Shah , and others, overseeing the company’s strategic and corporate governance.

Directors at Hemant Surgical Industries are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Mr. Hanskumar Shah is the current chairman at Hemant Surgical Industries.

Executive directors at Hemant Surgical Industries are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Hemant Surgical Industries adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Hemant Surgical Industries, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.